Fulgent Genetics, Inc. provided earning guidance for second quarter of 2022. For the second quarter of 2022, the company expects Total Revenue of approximately $125 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.39 USD | +1.18% | -3.26% | -26.01% |
05-03 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
05-03 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.01% | 640M | |
-23.69% | 7.86B | |
+68.36% | 4.32B | |
+2.12% | 2.63B | |
-6.65% | 2.5B | |
-41.95% | 2.33B | |
-11.99% | 1.82B | |
-21.34% | 1.51B | |
+17.44% | 1.22B | |
-43.89% | 1.14B |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earning Guidance for Second Quarter of 2022